Bristol-Myers Squibb Company http://www.alacrastore.com/company-snapshot/Bristol_Myers_Squibb_Company-1002495 08 Nov 2009 03:27:19 EST 1002495 Bristol-Myers Squibb Company en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/bir/541809541809bir/541809norm17Bristol-Myers Squibb Co.Acordis Specialty FibresDuPont Chemicals L.P.DuPont PharmaceuticalsDuPont Pharma, Inc.Kosan Biosciences Inc.United States04 Nov 2009 06:22:33 ESTBristol-Myers Squibb Company (BMS) was originally founded and established by two former fraternity brothers, William McLaren Bristol and John Ripley Myers and began trading on the New York Stock Exchange (NYSE) July 5, 1929, later incorporating in the staNYSE325412M2834I5417108731BMYBristol-Myers Squibb Company (BMS) was originally founded and established by two former fraternity brothers, William McLaren Bristol and John Ripley Myers and began trading on the New York Stock Exchange (NYSE) July 5, 1929, later incorporating in the staCompany Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39355808BW-0001-39355808newstex/BW-0001-39355808xmlNewstex Inc.2005Albany Molecular Research, Inc.Newstex Inc.newstex.comnewstexBW-0001-39355808Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400200004002006040160000401601302 Nov 2009 09:36:05 EST18000000180220001801500011/2/2009 Nov. #, #### (Business Wire) -- AMRI (NASDAQ: AMRI) announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company (NYSE: BMY) will proceed into preclinical development....Albany Molecular Research, Inc.BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEAMRIBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2387860B2387860ccbn/B2387860norm22 Oct 2009 02:07:00 EST2387860Edited Brief of BMY earnings conference call or presentation, 22-Oct-09 10:30am ETBristol-Myers Squibb54.0000EditedBristol-Myers Squibb Q3 2009 Earnings Conference Call SummaryBMY10:30am ETBrief...John Elicker Bristol-Myers Squibb - VP, IR Jim Cornelius Bristol-Myers Squibb - Chairman, CEO Jean-Marc Huet Bristol-Myers Squibb - CFO Elliott Sigal Bristol-Myers Squibb - Chief Scientific Officer Lamberto Andreotti Bristol-Myers Squibb - President... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2387860T2387860ccbn/T2387860norm22 Oct 2009 02:07:00 EST2387860Final Transcript of BMY earnings conference call or presentation, 22-Oct-09 10:30am ETBristol-Myers Squibb54.0000FinalBristol-Myers Squibb Q3 2009 Earnings Conference Call TranscriptBMY10:30am ETTranscript...John Elicker Bristol-Myers Squibb - VP, IR Jim Cornelius Bristol-Myers Squibb - Chairman, CEO Jean-Marc Huet Bristol-Myers Squibb - CFO Elliott Sigal Bristol-Myers Squibb - Chief Scientific Officer Lamberto Andreotti Bristol-Myers Squibb - President... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39057260BW-0001-39057260newstex/BW-0001-39057260xmlNewstex Inc.2005Bristol-Myers Squibb CompanyNewstex Inc.newstex.comnewstexBW-0001-39057260Business Wire0001Business WireBW1Newstex Inc.Business Wire0700000007005000070130000400000004002000040020060401600004016048040160180401600104016005040160310400600004006005040100000401000107014000070140080701401207014006070140090701401413000000130100001301000502000000020020000200200622 Oct 2009 08:23:41 EST1800000018008000180040001802000018016000180180001900000019002000190020071900200419002013190010001900103510/22/2009 Oct. ##, #### (Business Wire) -- Bristol-Myers Squibb Company (NYSE:BMY) today reported strong sales and earnings growth for the third quarter ####. “The performance in the third quarter of #### clearly shows the results of our outstanding...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEJAMES M CORNELIUSBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38860048BW-0001-38860048newstex/BW-0001-38860048xmlNewstex Inc.2005Five Prime Therapeutics, Inc.Newstex Inc.newstex.comnewstexBW-0001-38860048Business Wire0001Business WireBW1Newstex Inc.Business Wire0900000009015000070000000700500004000000040020000400200604016000040160010400600004006001070030000700300115 Oct 2009 09:25:33 EST180000001800700010/15/2009 Oct. ##, #### (Business Wire) -- Five Prime Therapeutics, Inc. today announced the appointment of three executives to its management team. Aron Knickerbocker joins as vice president business development , Marc Belsky as vice president...AMGEN INCBRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEAMGNBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38747030BW-0001-38747030newstex/BW-0001-38747030xmlNewstex Inc.2005Phyton Biotech GmbHNewstex Inc.newstex.comnewstexBW-0001-38747030Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040020000400200104002006040160000401603102000000020020000200200813000000130100001301000512 Oct 2009 04:27:29 EST18000000180180001900000019003000190020001900200710/12/2009 Oct. ##, #### (Business Wire) -- Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38488155BW-0001-38488155newstex/BW-0001-38488155xmlNewstex Inc.2005Harvard Clinical Research InstituteNewstex Inc.newstex.comnewstexBW-0001-38488155Business Wire0001Business WireBW1Newstex Inc.Business Wire070000000701300007005000040000000400200004002006040060000400600504016000040160310700100007001005070140000701401207014009070030000700300102 Oct 2009 08:20:24 EST18000000180180001900000019001000190010211900200410/2/2009 Oct. #, #### (Business Wire) -- The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study , marking the official initiation of the four-year clinical trial to investigate...BOSTON SCIENTIFIC CORPBRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEMEDTRONIC INCBMYBMY PRBSXMDTNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38226545BW-0001-38226545newstex/BW-0001-38226545xmlNewstex Inc.2005Bristol-Myers Squibb CompanyNewstex Inc.newstex.comnewstexBW-0001-38226545Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000401600004016005040020000400200602000000020020000200200624 Sep 2009 03:21:33 EST18000000180160009/24/2009 Sep. ##, #### (Business Wire) -- Medarex, Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company (NYSE: BMY), issued, under the terms of the indenture for Medarex’s #.##% Convertible Senior Notes due May ##, #### (the “Convertible...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38012944BW-0001-38012944newstex/BW-0001-38012944xmlNewstex Inc.2005AVEO Pharmaceuticals, Inc.Newstex Inc.newstex.comnewstexBW-0001-38012944Business Wire0001Business WireBW1Newstex Inc.Business Wire070000000700500009000000090150000701400007014008070140120700100007001004070030000700300104000000040020000400200604016000040160080401600213000000130100001301000516 Sep 2009 09:29:24 EST180000001800700019000000190010009/16/2009 Sep. ##, #### (Business Wire) -- AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced the...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLECANCER THERAPEUTICS INC.PFIZER INCBMYBMY PRCTHPPFENewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38004206BW-0001-38004206newstex/BW-0001-38004206xmlNewstex Inc.2005Bristol-Myers Squibb CompanyNewstex Inc.newstex.comnewstexBW-0001-38004206Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400200004002006040160000401600304016001070000000701400007014012070030000700300113000000130100001301000516 Sep 2009 01:14:55 EST1800000018020000180040001900000019003000190020001900200419002013190020091900201619001000190010359/16/2009 Sep. ##, #### (Business Wire) -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has reached an agreement for the sale of its OTC assets in Asia Pacific (excluding China and Japan) to Taisho Pharmaceutical Co., Ltd....BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEBMYBMY PRNewsNewstexhttp://www.alacrastore.com/storecontent/fitch/466208_report_frame466208_report_framefitch/466208_report_framepdfBristol-Myers Squibb Company8036141915 Sep 2009 02:18:00 EST01031700165Credit UpdateBMYFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/ccbn/T2400713T2400713ccbn/T2400713norm14 Sep 2009 04:04:00 EST2400713Final Transcript of BMY presentation, 14-Sep-09 2:10pm ETBristol-Myers Squibb54.0000FinalBristol-Myers Squibb at Morgan Stanley Global Healthcare Conference TranscriptBMY2:10pm ETTranscript... - President and COO John Elicker Bristol-Myers Squibb Company - IR C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/fitch/465796_report_frame465796_report_framefitch/465796_report_framepdfEli Lilly & CompanyLifepoint Hospitals, Inc.Covidien PLCTenet Healthcare CorporationPfizer Inc.Allergan, Inc.McKesson CorporationJohnson & JohnsonWyethAbbott LaboratoriesDaVita, Inc.Owens & Minor, Inc.Medco Health Solutions, IncAmerisourceBergen CorporationWatson Pharmaceuticals, Inc.HCA Inc.Amgen, Inc.Community Health Systems, Inc.Bristol-Myers Squibb CompanyLife Technologies CorporationMerck & Company, Inc.Beckman Coulter, Inc.Baxter International, Inc.Health Management Associates, Inc.Thermo Fisher Scientific IncUniversal Health Services, Inc.St. Jude Medical, Inc.Schering-Plough CorporationCardinal Health, Inc.Express Scripts, Inc.Boston Scientific Corporation8009020680361419816834998009174080089368800917738009111380090628800900878009159181841365800893698008991881841371800895268009116682508772816096558580007380361630803613728184138080710410806562368168347280361592800910138084388485094473829531258009208711 Sep 2009 06:34:00 EST01031700275Special ReportLPNTOMIPFECYHWPITHCABTLLYDVABMYHMATMOWYEBAXAMGNESRXLIFEMHSABCMRKJNJBSXCAHCOVAGNMCKBECSTJSGPUHSFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/465450_report_frame465450_report_framefitch/465450_report_framepdfEli Lilly & CompanySanofi-Aventis S.A.Glaxosmithkline Finance PlcWyethPfizer Inc.Merck & Company, Inc.Roche Holding Ltd.Bristol-Myers Squibb CompanyAbbott LaboratoriesJohnson & JohnsonAstraZeneca plcBayer AGNovartis AGSchering-Plough CorporationAmgen, Inc.85884073803616308045797680656236803615928084388480361372803624348071041080361419811087078009174082588683850944738045797910 Sep 2009 02:17:00 EST01031700275Special ReportJNJWYESANBMYAMGNABTROBAYNMRKPFELLYSGPAZNNOVNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch ResearchAUSTRALIA - Sigma Pharmaceuticals Ltd agreed to acquire a manufacturing facility, located in Noble Park, Victoria, from Bristol- Myers Squibb Co, a New York- based manufacturer of pharmaceuticals and medical products, for AUD ## mil (USD ##.### mil) in cash.08 Sep 2009 08:18:49 EST82717N11010R82717N110122Sigma Pharmaceuticals LtdBristol-Myers Squibb Co- Manufacturing Facility,Noble Park,VictoriaSigma Pharmaceuticals LtdBristol-Myers Squibb Cohttp://www.alacrastore.com/storecontent/Thomson_M%26A/Sigma_Pharmaceuticals_Ltd_acquires_Bristol_Myers_Squibb_Co_Mnfg_from_Bristol_Myers_Squibb_Co-2105834040sdc/21058340402105834040Copyright © 2009, Thomson Financial, All Rights ReservedAustraliaDrugsAustraliaPharmaceutical preparations2834FFForeignPublicSIP2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries5912:Drug stores and proprietary stores2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries5912:Drug stores and proprietary storesDrugsAustraliaPharmaceutical preparations2834FFForeignSubsidiary789091004Mnfr,whl pharmMnfr pharm,med prodCashCash OnlyAssets1103251001Sep 8 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000Sigma Pharmaceuticals Ltd,located in Victoria,Australia, manufactures andwholesales prescription,over-the-counter and genericpharmaceutical products. Thecompany was founded in 1912.Sigma Pharmaceuticals Ltd, located in Victoria, Australia,manufactures and wholesales prescription, over-the-counterand generic pharmaceutical products. The company was foundedin 1912.Sigma Pharmaceuticals Ltd, located in Victoria, Australia, manufactures and wholesales prescription, over-the-counter and generic pharmaceutical products. The company was founded in 1912.1.000002.000003.000004.00000The asset is comprised ofBristol-Myers Squibb Co'smanufacturing facility inNoble Park, Victoria.The asset is comprised of Bristol-Myers Squibb Co'smanufacturing facility in Noble Park, Victoria.The asset is comprised of Bristol-Myers Squibb Co's manufacturing facility in Noble Park, Victoria.0.000000.000000.000000.00000NAustralian Dollar07 Sep 09Mon, 07 Sep 2009 00:00:00 ESTDate Announced: 09/07/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000060 Australian Dollar60.000000.0000060 Australian Dollar60.000000.000000.000000.000000.0000060.0000060 Australian Dollar0.85100N31.175000.000000.000000.000000.000000.0000051.0840051.084000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000AUSTRALIA - SigmaPharmaceuticals Ltd agreed toacquire a manufacturingfacility, located in NoblePark, Victoria, from Bristol-Myers Squibb Co, a New York-based manufacturer ofpharmaceuticals and medicalproducts, for AUD 60 mil (USD51.084 mil) in cash.AUSTRALIA - Sigma Pharmaceuticals Ltd agreed to acquire a manufacturing facility, located in Noble Park, Victoria, from Bristol- Myers Squibb Co, a New York- based manufacturer of pharmaceuticals and medical products, for AUD 60 mil (USD 51.084 mil) in cash.AUSTRALIA - Sigma Pharmaceuticals Ltd agreed to acquire a manufacturing facility, locatedin Noble Park, Victoria, from Bristol- Myers Squibb Co, a New York- based manufacturer ofpharmaceuticals and medical products, for AUD 60 mil (USD 51.084 mil) in cash.AUSTRALIA - Sigma Pharmaceuticals Ltd agreed to acquire a manufacturing facility, located in Noble Park, Victoria, from Bristol- Myers Squibb Co, a New York- based manufacturer of pharmaceuticals andmedical products, for AUD 60 mil (USD 51.084 mil) in cash.AUSTRALIA - Sigma Pharmaceuticals Ltd agreed to acquire a manufacturing facility, located in Noble Park, Victoria, from Bristol- MyersSquibb Co, a New York- based manufacturer of pharmaceuticals and medical products, for AUD 60 mil (USD 51.084 mil) in cash.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002023:Dry, condensed, and evaporated dairy products2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances2842:Specialty cleaning and polishing preparations2844:Perfumes, cosmetics, and other toilet preparations3634:Electric housewares and fans3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies8731:Commercial physical and biological research789091004AustraliaAustralia2834ForeignPublicSIP2023:Dry, condensed, and evaporated dairy products2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances2842:Specialty cleaning and polishing preparations2844:Perfumes, cosmetics, and other toilet preparations3634:Electric housewares and fans3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies8731:Commercial physical and biological research7579002New YorkUnited States2834New YorkPublicBMY51.0840060.0000051.0840031.17500Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-37666799MCOM-0004-37666799newstex/MCOM-0004-37666799xmlNewstex Inc.2005Copyright (c) M2 Communications Ltd.Newstex Inc.newstex.comnewstexMCOM-0004-37666799M2 EquityBites0004M2 Communications Ltd.MCOM1Newstex Inc.M204000000040160000401600504016019040020000400200602000000020020000200200602 Sep 2009 02:48:07 EST1800000018016000180130009/2/2009 Sep. #, #### (M# Communications Ltd. delivered by Newstex) -- Biopharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) declared on Tuesday that shareholders of Medarex Inc (NASDAQ:MEDX) have tendered approximately ###,###,###...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEMEDAREX INCBMYBMY PRMEDXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-37656780BW-0001-37656780newstex/BW-0001-37656780xmlNewstex Inc.2005Bristol-Myers Squibb CompanyNewstex Inc.newstex.comnewstexBW-0001-37656780Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040160000401600504016019040020000400200602000000020020000200200602 Sep 2009 02:47:27 EST1800000018016000180130001900000019001000190010329/2/2009 Sep. #, #### (Business Wire) -- Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has completed its previously announced $#.# billion acquisition of Medarex, Inc. (NASDAQ: MEDX) (“Medarex”). As a result of the transaction,...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEMEDAREX INCBMYBMY PRMEDXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-37639555BW-0001-37639555newstex/BW-0001-37639555xmlNewstex Inc.2005Bristol-Myers Squibb CompanyNewstex Inc.newstex.comnewstexBW-0001-37639555Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000401600004016005040160190401600304016001040020000400200602000000020020000200200601 Sep 2009 09:34:37 EST1800000018016000180130001900000019001000190010359/1/2009 Sep. #, #### (Business Wire) -- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the depositary for its tender offer for all the outstanding common stock of Medarex has advised that, as of the expiration of the subsequent...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEMEDAREX INCBMYBMY PRMEDXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-37533318BW-0001-37533318newstex/BW-0001-37533318xmlNewstex Inc.2005Fitch RatingsNewstex Inc.newstex.comnewstexBW-0001-37533318Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040090000400900104016000040160310401604802000000020020000200200807000000070140000701401227 Aug 2009 11:26:59 EST180000001801800018024000180090008/27/2009 Aug. ##, #### (Business Wire) -- Fitch Ratings has affirmed Bristol-Myers Squibb Co.'s (Bristol-Myers Squibb) ratings as follows: --Long-term Issuer Default Rating (IDR) at 'A+'; --Senior unsecured debt at 'A+'; --Bank loan at 'A+';...BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLEBMYBMY PRNewsNewstex